These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11347750)

  • 1. Elevation of N-(carboxymethyl)valine residue in hemoglobin of diabetic patients. Its role in the development of diabetic nephropathy.
    Uchimura T; Nakano K; Hashiguchi T; Iwamoto H; Miura K; Yoshimura Y; Hanyu N; Hirata K; Imakuma M; Motomiya Y; Maruyama I
    Diabetes Care; 2001 May; 24(5):891-6. PubMed ID: 11347750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-(carboxymethyl)valine residues in hemoglobin (CMV-Hb) reflect accumulation of oxidative stress in diabetic patients.
    Shimada S; Tanaka Y; Ohmura C; Tamura Y; Shimizu T; Uchino H; Watada H; Hirose T; Nakaniwa T; Miwa S; Kawamori R
    Diabetes Res Clin Pract; 2005 Sep; 69(3):272-8. PubMed ID: 16098924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes.
    Tan KC; Shiu SW; Chow WS; Leng L; Bucala R; Betteridge DJ
    Diabetologia; 2006 Nov; 49(11):2756-62. PubMed ID: 16969649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased serum levels of advanced glycation end-products and diabetic complications.
    Ono Y; Aoki S; Ohnishi K; Yasuda T; Kawano K; Tsukada Y
    Diabetes Res Clin Pract; 1998 Aug; 41(2):131-7. PubMed ID: 9789719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of advanced glycation endproducts on haemoglobin (Hb-AGE) and haemoglobin A1c for the assessment of diabetic control.
    Turk Z; Mesić R; Benko B
    Clin Chim Acta; 1998 Oct; 277(2):159-70. PubMed ID: 9853699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Hemoglobin Glycation Using Microfluidic CE-MS: A Rapid, Mass Spectrometry Compatible Method for Assessing Diabetes Management.
    Redman EA; Ramos-Payan M; Mellors JS; Ramsey JM
    Anal Chem; 2016 May; 88(10):5324-30. PubMed ID: 27100069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted quantification of N-1-(carboxymethyl) valine and N-1-(carboxyethyl) valine peptides of β-hemoglobin for better diagnostics in diabetes.
    Jagadeeshaprasad MG; Batkulwar KB; Meshram NN; Tiwari S; Korwar AM; Unnikrishnan AG; Kulkarni MJ
    Clin Proteomics; 2016; 13():7. PubMed ID: 27030792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes.
    Berg TJ; Snorgaard O; Faber J; Torjesen PA; Hildebrandt P; Mehlsen J; Hanssen KF
    Diabetes Care; 1999 Jul; 22(7):1186-90. PubMed ID: 10388987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of nephropathy in type 2 diabetes: the glycation gap is a significant predictor after adjustment for glycohemoglobin (Hb A1c).
    Rodríguez-Segade S; Rodríguez J; Cabezas-Agricola JM; Casanueva FF; Camiña F
    Clin Chem; 2011 Feb; 57(2):264-71. PubMed ID: 21147957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and quantitation of N-(carboxymethyl)valine adduct in hemoglobin by gas chromatography/mass spectrometry.
    Cai J; Hurst HE
    J Mass Spectrom; 1999 May; 34(5):537-43. PubMed ID: 10390858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced glycation end products in serum predict changes in the kidney morphology of patients with insulin-dependent diabetes mellitus.
    Berg TJ; Bangstad HJ; Torjesen PA; Osterby R; Bucala R; Hanssen KF
    Metabolism; 1997 Jun; 46(6):661-5. PubMed ID: 9186302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased serum levels of pentosidine, but not carboxymethyl lysine, in type 2 diabetes without obvious diabetic nephropathy.
    Daimon M; Ono Y; Saito T; Yamaguchi H; Hirata A; Ohnuma H; Igarashi M; Eguchi H; Manaka H; Kato T
    Diabetes Care; 1999 May; 22(5):877-8. PubMed ID: 10332715
    [No Abstract]   [Full Text] [Related]  

  • 13. 3'-
    Pérez Gutierrez RM; García Campoy AH; Paredes Carrera SP; Muñiz Ramirez A; Mota Flores JM; Flores Valle SO
    Molecules; 2019 Mar; 24(7):. PubMed ID: 30925713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries.
    Schalkwijk CG; Ligtvoet N; Twaalfhoven H; Jager A; Blaauwgeers HG; Schlingemann RO; Tarnow L; Parving HH; Stehouwer CD; van Hinsbergh VW
    Diabetes; 1999 Dec; 48(12):2446-53. PubMed ID: 10580435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycated albumin and ratio of glycated albumin to glycated hemoglobin are good indicators of diabetic nephropathy in type 2 diabetes mellitus.
    Wang N; Xu Z; Han P; Li T
    Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27537245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal glycation of proteins and peptides in foods and in vivo: evaluation of N-(2-furoylmethyl)valine in acid hydrolyzates of human hemoglobin.
    Penndorf I; Li C; Schwarzenbolz U; Henle T
    Ann N Y Acad Sci; 2008 Apr; 1126():118-23. PubMed ID: 18448804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldimine Formation Reaction, the First Step of the Maillard Early-phase Reaction, Might be Enhanced in Variant Hemoglobin, Hb Himeji.
    Koga M; Inada S; Shimizu S; Hatazaki M; Umayahara Y; Nishihara E
    Ann Clin Lab Sci; 2015; 45(6):643-9. PubMed ID: 26663794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum concentrations of advanced glycation endproducts are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetes.
    Aso Y; Inukai T; Tayama K; Takemura Y
    Acta Diabetol; 2000; 37(2):87-92. PubMed ID: 11194933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced glycation end products in adolescents and young adults with diabetic angiopathy.
    Chiarelli F; Catino M; Tumini S; Cipollone F; Mezzetti A; Vanelli M; Verrotti A
    Pediatr Nephrol; 2000 Aug; 14(8-9):841-6. PubMed ID: 10955941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of decline in renal function in the diabetic db/db mouse.
    Cohen MP; Clements RS; Cohen JA; Shearman CW
    Diabetologia; 1996 Mar; 39(3):270-4. PubMed ID: 8721771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.